Search

The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOPES) to better reflect its widespread health effects, following a collaborative effort by an international consortium of medical professionals and researchers who aimed to address the diagnostic confusion and stigmatization faced by many patients, ultimately advocating for a broader understanding and approach to treatment. #Health #EndocrineDisorder #PCOS #AU #US

The condition formerly known as polycystic ovary syndrome (PCOS) has been renamed as polyendocrine metabolic ovarian syndrome (POMP) to better reflect its extensive health impacts and address misconceptions surrounding its diagnosis and treatment, as concluded by an international consortium of medical professionals and researchers. #HealthAwareness #EndocrineDisorders #WomenHealth #AU #US #CO

The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOMP) to better reflect its broad health impacts and to combat misdiagnosis and stigma, as highlighted by an international consortium of medical professionals, who aim to improve understanding and treatment of the disorder affecting a significant percentage of reproductive-age women and transgender individuals. #Health #WomenHealth #EndocrineDisorder #AU

The condition previously known as polycystic ovary syndrome (P.C.O.S.) has been renamed polyendocrine metabolic ovarian syndrome (P.M.O.S.) to more accurately reflect its diverse health implications and encourage better diagnosis, treatment, and awareness among both patients and healthcare providers. #WomenHealth #MetabolicSyndrome #EndocrineDisorders #AUS #US

The condition formerly known as polycystic ovary syndrome (P.C.O.S.) has been renamed polyendocrine metabolic ovarian syndrome (P.M.O.S.) to more accurately reflect its diverse health implications, as an international consortium of experts seeks to improve diagnosis and treatment for the 10-13% of reproductive-age women affected by it. #WomenHealth #EndocrineDisorders #HealthAwareness #AUS #USA

An international consortium has renamed polycystic ovary syndrome (P.C.O.S.) to polyendocrine metabolic ovarian syndrome (P.M.O.S.) to more accurately reflect its complex hormonal and metabolic effects, aiming to improve diagnosis, treatment, and funding for the condition, which affects 10-13% of reproductive-age women. #WomensHealth #EndocrineDisorders #MedicalResearch #AU #US

The condition formerly known as polycystic ovary syndrome (P.C.O.S.) has been renamed polyendocrine metabolic ovarian syndrome (P.M.O.S.) to better capture its complex hormonal and metabolic effects and to improve diagnosis, treatment, and research opportunities for the 10 to 13 percent of reproductive-age women it affects. #WomensHealth #EndocrineDisorder #MetabolicSyndrome #AU #US

The condition formerly known as polycystic ovary syndrome (P.C.O.S.) has been renamed polyendocrine metabolic ovarian syndrome (P.M.O.S.) to more accurately reflect its hormonal and metabolic impacts beyond just ovarian issues, aiming to improve diagnosis, treatment, and research funding for the estimated 10 to 13 percent of reproductive-age women affected by it. #WomensHealth #EndocrineDisorders #MetabolicSyndrome #AU #US

The condition previously known as polycystic ovary syndrome (PCOS) has been rebranded as polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its broad health implications, aiming to enhance diagnosis, treatment, and understanding of the syndrome's effects beyond reproductive health. #WomenHealth #EndocrineDisorders #MetabolicSyndrome #AU #US